Model Information | Number |
---|---|
Total Number of Variables | |
Total Number of State Variables (Level+Smooth+Delay Variables) | |
Total Number of Stocks (Stocks in Level+Smooth+Delay Variables) † | |
Total Number of Macros | |
Function Sensitivity Parameters | |
Variables with Source Information | |
Data Lookup Tables | |
Time Unit | |
Initial Time | |
Final Time | |
Time Step | |
Model Is Fully Formulated | |
Modeler-Defined Groups | |
VPM File Available |
Types: |
|
|||||||||||||||
* (state variables / total stocks) | ||||||||||||||||
* * Feature not yet implemented. | ||||||||||||||||
† Total stocks do not include fixed delay variables. | ||||||||||||||||
†† (lookup variables / lookup tables). | ||||||||||||||||
Groups: |
|
|||||||||||||||
Modules: |
|
|||||||||||||||
Views: |
|
|||||||||||||||
Search: | ••• a-b c-d e-f g-h i-j k-l m-n o-p q-r s-t u-v w-x y-z ••• |
Variable Name and Description | |||
Default | CMV USA (Default) |
F,A
![]() ![]() |
becoming uninfectious (person/Year)
= Infectious adults/duration of the infection Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
birth rate (1/Year)
= 0.0135 Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
chance of transmission seropositive (Dmnl)
= 0.014*(1-Policy 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
children becoming uninfectious (person/Year)
= Infectious children/duration of the infection Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
children contact rate (contact/(person*Year))
= 40*(1-Policy 4) Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Children with CMV-induced Mental Retardation (person)
= ∫MR after primary infection in T1+MR after primary infection in T2+MR after seropositive transmission-severely disabled death dt + [initial value MR children] Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Children with CMV-induced SNHL aged 2 (person)
= ∫SNHL after infection in T1+SNHL after infection in T2+SNHL after seropositive transmission-growth SNHL children dt + [initial value SNHL children] Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
contact rate among pregnant women (contact/(person*Year))
= 40*(1-Policy 1) Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
Disabled children due to CMV (person)
= Children with CMV-induced Mental Retardation+Children with CMV-induced SNHL aged 2 Present in 1 view: |
Default | CMV USA (Default) |
C
![]() |
duration of infancy (Year)
= 1.5 Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
duration of the infection (Year)
= 1.5 Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
fatality ratio of symptomatic infant (Dmnl)
= 0.07*(1+Policy 3.1) Present in 1 view: Used by: |
Default | Control | C
![]() |
FINAL TIME (Year)
= 100 Description: The final time for the simulation. Not Present In Any View |
Default | CMV USA (Default) |
A
![]() |
fraction of CMV-induced disabled children (Dmnl)
= (Children with CMV-induced SNHL aged 2+Children with CMV-induced Mental Retardation)/(Children with CMV-induced SNHL aged 2+Children with CMV-induced Mental Retardation+Infectious healthy children aged 2+Non infected children aged 2) Present in 1 view: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
growth (person/Year)
= Non infected children/growth time Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
growth infectious children (person/Year)
= Infectious healthy children aged 2/duration of infancy Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
growth non infected between 2 and 3.5 (person/Year)
= DELAY N(non infected after T1+non infected after T2+healthy from seronegative deliveries+non infected from seropositive mothers, duration of infancy, MAX(non infected after T1+non infected after T2+healthy from seronegative deliveries+non infected from seropositive mothers-(Non infected children aged 2*risk of acquiring infection in children), 0), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
growth SNHL children (person/Year)
= Children with CMV-induced SNHL aged 2/duration of infancy Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
growth time (Year)
= 15 Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
growth with cmv (person/Year)
= Non infectious seropositive children/growth time Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
healthy from seronegative deliveries (person/Year)
= DELAY N(seronegative deliveries, 2, seronegative deliveries, 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
Infected children (person)
= Children with CMV-induced Mental Retardation+Infectious healthy children aged 2+Children with CMV-induced SNHL aged 2 Present in 1 view: |
Default | CMV USA (Default) |
A
![]() |
infected fraction of the population (Dmnl)
= (Children with CMV-induced Mental Retardation+Children with CMV-induced SNHL aged 2+Infectious adults+Infectious healthy children aged 2)/total population Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
infections in adults (person/Year)
= Seronegative adults*risk of acquiring infection in adults Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
infections in children (person/Year)
= Non infected children*risk of acquiring infection in children Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Infectious adults (person)
= ∫infections in adults-becoming uninfectious dt + [1.5e+006] Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
infectious after seropositive transmission (person/Year)
= DELAY N( Pregnancies of seropositive mothers*chance of transmission seropositive*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*(1-percentage of symptomatic seropositive that shows CNS signs)/(3*trimester)+(1-percentage of primary symptomatic infant)*(1-percentage of asymptomatic seropositive that shows CNS signs)/(3*trimester)), 2, Pregnancies of seropositive mothers*chance of transmission seropositive*((1-fatality ratio of symptomatic infant)/(3*trimester)), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
infectious after T1 (person/Year)
= DELAY N(primary infections T1*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*(1-percentage of symptomatic after T1 that shows CNS signs)+(1-percentage of primary symptomatic infant)*(1-percentage of asymptomatic after T1 that shows signs of CNS)), 2.5, primary infections T1*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
infectious after T2 (person/Year)
= DELAY N(primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*(1-percentage of infant T2 that shows CNS signs)+(1-percentage of primary symptomatic infant)*(1-percentage of infant T2 that shows CNS signs)), 2.25, primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Infectious children (person)
= ∫growth infectious children+growth SNHL children+infections in children-children becoming uninfectious dt + [1.5e+006] Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Infectious healthy children aged 2 (person)
= ∫infectious after seropositive transmission+infectious after T1+infectious after T2-growth infectious children dt + [initial value infectious healthy children] Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
infectivity (person/contact)
= 0.04*(1-Policy 5) Present in 1 view: Used by: |
Default | Control | C
![]() |
INITIAL TIME (Year)
= 0 Description: The initial time for the simulation. Not Present In Any View Used by:
|
Default | CMV USA (Default) |
LI,C
![]() |
initial value infectious healthy children (person)
= 32000 Present in 1 view: Used by: |
Default | CMV USA (Default) |
LI,C
![]() |
initial value MR children (person)
= 3500 Present in 1 view: Used by: |
Default | CMV USA (Default) |
LI,C
![]() |
initial value non infected children (person)
= 360000 Present in 1 view: Used by: |
Default | CMV USA (Default) |
LI,C
![]() |
initial value seronegative pregnancies T1 (person)
= 50000 Present in 1 view: Used by: |
Default | CMV USA (Default) |
LI,C
![]() |
initial value seropositive pregnancies (person)
= 50000 Present in 1 view: Used by: |
Default | CMV USA (Default) |
LI,C
![]() |
initial value SNHL children (person)
= 6000 Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
inter adult contact rate (contact/(Year*person))
= 40*(1-Policy 4) Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
life expectancy (Year)
= 60 Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
MR after primary infection in T1 (person/Year)
= DELAY N(primary infections T1*transmission rate after primary infection*(percentage of primary symptomatic infant*(1-fatality ratio of symptomatic infant)*percentage of symptomatic after T1 that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of asymptomatic after T1 that shows signs of CNS)*percentage of CNS that leads to serious MR, 2.5, primary infections T1*transmission rate after primary infection*(1-fatality ratio of symptomatic infant), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
MR after primary infection in T2 (person/Year)
= DELAY N(primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*percentage of infant T2 that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of infant T2 that shows CNS signs)*percentage of CNS that leads to serious MR, 2.25, primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
MR after seropositive transmission (person/Year)
= DELAY N(Pregnancies of seropositive mothers*chance of transmission seropositive*(percentage of primary symptomatic infant*(1-fatality ratio of symptomatic infant)*percentage of symptomatic seropositive that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of asymptomatic seropositive that shows CNS signs)*percentage of CNS that leads to serious MR/(3*trimester), 2, Pregnancies of seropositive mothers*chance of transmission seropositive/(3*trimester), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
multiple birth coefficient (Dmnl)
= 1.04 Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
non infected 2nd T (person/Year)
= Seronegative pregnancies T1*((1/trimester)-risk of acquiring infection in pregnancy) Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
non infected after T1 (person/Year)
= DELAY N(primary infections T1*(1-transmission rate after primary infection), 2.5, primary infections T1*(1-transmission rate after primary infection), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
non infected after T2 (person/Year)
= DELAY N(primary infections T2*(1-transmission rate after primary infection), 2.25, primary infections T2*(1-transmission rate after primary infection), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Non infected children (person)
= ∫growth non infected between 2 and 3.5-growth-infections in children dt + [1.5e+007] Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Non infected children aged 2 (person)
= ∫healthy from seronegative deliveries+non infected after T1+non infected after T2+non infected from seropositive mothers-growth non infected between 2 and 3.5 dt + [initial value non infected children] Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
non infected from seropositive mothers (person/Year)
= DELAY N(Pregnancies of seropositive mothers*(1-chance of transmission seropositive)/(3*trimester), 2, Pregnancies of seropositive mothers*(1-chance of transmission seropositive)/(3*trimester), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
non infected T3 (person/Year)
= Seronegative pregnancies T2*((1/trimester)-risk of acquiring infection in pregnancy) Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Non infectious seropositive adults (person)
= ∫becoming uninfectious+growth with cmv-seropositive adult death dt + [2e+008] Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Non infectious seropositive children (person)
= ∫children becoming uninfectious-growth with cmv dt + [1.5e+007] Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
percentage of asymptomatic after T1 that shows signs of CNS (Dmnl)
= 0.5*(1-Policy 3.2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
percentage of asymptomatic seropositive that shows CNS signs (Dmnl)
= 0.1 Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
percentage of CNS that leads to serious MR (Dmnl)
= 0.25 Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
percentage of infant T2 that shows CNS signs (Dmnl)
= 0.08*(1-Policy 3.2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
percentage of primary symptomatic infant (Dmnl)
= 0.18 Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
percentage of symptomatic after T1 that shows CNS signs (Dmnl)
= 0.8*(1-Policy 3.2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
percentage of symptomatic seropositive that shows CNS signs (Dmnl)
= 0.5 Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
Policy 1 (contact/(person*Year))
= 0.5*switch 1 Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
Policy 2 (Dmnl)
= 0.2*switch 2 Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
Policy 3.1 (Dmnl)
= 1*switch 3.1 Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
Policy 3.2 (Dmnl)
= 0.4*switch 3 2 Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
Policy 4 (contact/(person*Year))
= 0.2*switch 4 Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
Policy 5 (person/contact)
= 0.5*switch 5 Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Pregnancies of seropositive mothers (person)
= ∫seropositive pregnancies-seropositive deliveries dt + [initial value seropositive pregnancies] Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
primary infections T1 (person/Year)
= Seronegative pregnancies T1*risk of acquiring infection in pregnancy Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
primary infections T2 (person/Year)
= Seronegative pregnancies T2*risk of acquiring infection in pregnancy Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
risk of acquiring infection in adults (1/Year)
= infected fraction of the population*infectivity*inter adult contact rate Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
risk of acquiring infection in children (1/Year)
= infectivity*infected fraction of the population*children contact rate Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
risk of acquiring infection in pregnancy (1/Year)
= infectivity*infected fraction of the population*contact rate among pregnant women Present in 1 view: Used by: |
Default | Control | A
![]() |
SAVEPER (Year [0,?])
= TIME STEP Description: The frequency with which output is stored. Not Present In Any View |
Default | CMV USA (Default) |
DE,F
![]() |
seronegative adult death (person/Year)
= DELAY N(growth, life expectancy, MAX(growth -(Seronegative adults*risk of acquiring infection in adults), 0), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Seronegative adults (person)
= ∫growth-infections in adults-seronegative adult death dt + [1e+008] Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
seronegative deliveries (person/Year)
= Seronegative pregnancies T3/trimester Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
seronegative pregnancies (person/Year)
= birth rate*multiple birth coefficient*Seronegative adults Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Seronegative pregnancies T1 (person)
= ∫seronegative pregnancies-non infected 2nd T-primary infections T1 dt + [initial value seronegative pregnancies T1] Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Seronegative pregnancies T2 (person)
= ∫non infected 2nd T-non infected T3-primary infections T2 dt + [0] Present in 1 view: Used by: |
Default | CMV USA (Default) |
L
![]() |
Seronegative pregnancies T3 (person)
= ∫non infected T3-seronegative deliveries dt + [0] Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
seropositive adult death (person/Year)
= Non infectious seropositive adults/life expectancy Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
seropositive deliveries (person/Year)
= Pregnancies of seropositive mothers/(3*trimester) Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
seropositive pregnancies (person/Year)
= (Infectious adults+Non infectious seropositive adults)*birth rate*multiple birth coefficient Present in 1 view: Used by: |
Default | CMV USA (Default) |
F,A
![]() ![]() |
severely disabled death (person/Year)
= Children with CMV-induced Mental Retardation/duration of infancy Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
SNHL after infection in T1 (person/Year)
= DELAY N(primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*percentage of symptomatic after T1 that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of asymptomatic after T1 that shows signs of CNS)*(1-percentage of CNS that leads to serious MR), 2.5, primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
SNHL after infection in T2 (person/Year)
= DELAY N(primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*percentage of infant T2 that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of infant T2 that shows CNS signs)*(1-percentage of CNS that leads to serious MR), 2.25, primary infections T2*transmission rate after primary infection*((1-fatality ratio of symptomatic infant)), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
DE,F
![]() |
SNHL after seropositive transmission (person/Year)
= DELAY N(Pregnancies of seropositive mothers*chance of transmission seropositive*((1-fatality ratio of symptomatic infant)*percentage of primary symptomatic infant*percentage of symptomatic seropositive that shows CNS signs+(1-percentage of primary symptomatic infant)*percentage of asymptomatic seropositive that shows CNS signs)*(1-percentage of CNS that leads to serious MR)/(3*trimester), 2, Pregnancies of seropositive mothers*chance of transmission seropositive*((1-fatality ratio of symptomatic infant))/(3*trimester), 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
switch 1 (contact/(person*Year))
= 0 Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
switch 2 (Dmnl)
= 0 Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
switch 3 2 (Dmnl)
= 0 Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
switch 3.1 (Dmnl)
= 0 Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
switch 4 (contact/(person*Year))
= 0 Present in 1 view: Used by: |
Default | CMV USA (Default) |
C
![]() |
switch 5 (person/contact)
= 0 Present in 1 view: Used by: |
Default | Control | C
![]() |
TIME STEP (Year [0,?])
= 0.0078125 Description: The time step for the simulation. Not Present In Any View Used by:
|
Default | CMV USA (Default) |
A
![]() |
total population (person)
= Infectious healthy children aged 2+Non infectious seropositive children+Children with CMV-induced SNHL aged 2+Non infected children aged 2+Infectious adults+Non infectious seropositive adults+Seronegative adults+Infectious children+Non infected children Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
transmission rate after primary infection (Dmnl)
= 0.35*(1-Policy 2) Present in 1 view: Used by: |
Default | CMV USA (Default) |
A
![]() |
trimester (Year)
= 3/12 Present in 1 view: Used by: |
Undocumented Variable (94) | |||
Default | CMV USA | F,A | becoming uninfectious (person/Year) |
Default | CMV USA | C | birth rate (1/Year) |
Default | CMV USA | A | chance of transmission seropositive (Dmnl) |
Default | CMV USA | F,A | children becoming uninfectious (person/Year) |
Default | CMV USA | A | children contact rate (contact/(person*Year)) |
Default | CMV USA | L | Children with CMV-induced Mental Retardation (person) |
Default | CMV USA | L | Children with CMV-induced SNHL aged 2 (person) |
Default | CMV USA | A | contact rate among pregnant women (contact/(person*Year)) |
Default | CMV USA | A | Disabled children due to CMV (person) |
Default | CMV USA | C | duration of infancy (Year) |
Default | CMV USA | C | duration of the infection (Year) |
Default | CMV USA | A | fatality ratio of symptomatic infant (Dmnl) |
Default | CMV USA | A | fraction of CMV-induced disabled children (Dmnl) |
Default | CMV USA | F,A | growth (person/Year) |
Default | CMV USA | F,A | growth infectious children (person/Year) |
Default | CMV USA | DE,F | growth non infected between 2 and 3.5 (person/Year) |
Default | CMV USA | F,A | growth SNHL children (person/Year) |
Default | CMV USA | C | growth time (Year) |
Default | CMV USA | F,A | growth with cmv (person/Year) |
Default | CMV USA | DE,F | healthy from seronegative deliveries (person/Year) |
Default | CMV USA | A | Infected children (person) |
Default | CMV USA | A | infected fraction of the population (Dmnl) |
Default | CMV USA | F,A | infections in adults (person/Year) |
Default | CMV USA | F,A | infections in children (person/Year) |
Default | CMV USA | L | Infectious adults (person) |
Default | CMV USA | DE,F | infectious after seropositive transmission (person/Year) |
Default | CMV USA | DE,F | infectious after T1 (person/Year) |
Default | CMV USA | DE,F | infectious after T2 (person/Year) |
Default | CMV USA | L | Infectious children (person) |
Default | CMV USA | L | Infectious healthy children aged 2 (person) |
Default | CMV USA | A | infectivity (person/contact) |
Default | CMV USA | LI,C | initial value infectious healthy children (person) |
Default | CMV USA | LI,C | initial value MR children (person) |
Default | CMV USA | LI,C | initial value non infected children (person) |
Default | CMV USA | LI,C | initial value seronegative pregnancies T1 (person) |
Default | CMV USA | LI,C | initial value seropositive pregnancies (person) |
Default | CMV USA | LI,C | initial value SNHL children (person) |
Default | CMV USA | A | inter adult contact rate (contact/(Year*person)) |
Default | CMV USA | C | life expectancy (Year) |
Default | CMV USA | DE,F | MR after primary infection in T1 (person/Year) |
Default | CMV USA | DE,F | MR after primary infection in T2 (person/Year) |
Default | CMV USA | DE,F | MR after seropositive transmission (person/Year) |
Default | CMV USA | C | multiple birth coefficient (Dmnl) |
Default | CMV USA | F,A | non infected 2nd T (person/Year) |
Default | CMV USA | DE,F | non infected after T1 (person/Year) |
Default | CMV USA | DE,F | non infected after T2 (person/Year) |
Default | CMV USA | L | Non infected children (person) |
Default | CMV USA | L | Non infected children aged 2 (person) |
Default | CMV USA | DE,F | non infected from seropositive mothers (person/Year) |
Default | CMV USA | F,A | non infected T3 (person/Year) |
Default | CMV USA | L | Non infectious seropositive adults (person) |
Default | CMV USA | L | Non infectious seropositive children (person) |
Default | CMV USA | A | percentage of asymptomatic after T1 that shows signs of CNS (Dmnl) |
Default | CMV USA | C | percentage of asymptomatic seropositive that shows CNS signs (Dmnl) |
Default | CMV USA | C | percentage of CNS that leads to serious MR (Dmnl) |
Default | CMV USA | A | percentage of infant T2 that shows CNS signs (Dmnl) |
Default | CMV USA | C | percentage of primary symptomatic infant (Dmnl) |
Default | CMV USA | A | percentage of symptomatic after T1 that shows CNS signs (Dmnl) |
Default | CMV USA | C | percentage of symptomatic seropositive that shows CNS signs (Dmnl) |
Default | CMV USA | A | Policy 1 (contact/(person*Year)) |
Default | CMV USA | A | Policy 2 (Dmnl) |
Default | CMV USA | A | Policy 3.1 (Dmnl) |
Default | CMV USA | A | Policy 3.2 (Dmnl) |
Default | CMV USA | A | Policy 4 (contact/(person*Year)) |
Default | CMV USA | A | Policy 5 (person/contact) |
Default | CMV USA | L | Pregnancies of seropositive mothers (person) |
Default | CMV USA | F,A | primary infections T1 (person/Year) |
Default | CMV USA | F,A | primary infections T2 (person/Year) |
Default | CMV USA | A | risk of acquiring infection in adults (1/Year) |
Default | CMV USA | A | risk of acquiring infection in children (1/Year) |
Default | CMV USA | A | risk of acquiring infection in pregnancy (1/Year) |
Default | CMV USA | DE,F | seronegative adult death (person/Year) |
Default | CMV USA | L | Seronegative adults (person) |
Default | CMV USA | F,A | seronegative deliveries (person/Year) |
Default | CMV USA | F,A | seronegative pregnancies (person/Year) |
Default | CMV USA | L | Seronegative pregnancies T1 (person) |
Default | CMV USA | L | Seronegative pregnancies T2 (person) |
Default | CMV USA | L | Seronegative pregnancies T3 (person) |
Default | CMV USA | F,A | seropositive adult death (person/Year) |
Default | CMV USA | F,A | seropositive deliveries (person/Year) |
Default | CMV USA | F,A | seropositive pregnancies (person/Year) |
Default | CMV USA | F,A | severely disabled death (person/Year) |
Default | CMV USA | DE,F | SNHL after infection in T1 (person/Year) |
Default | CMV USA | DE,F | SNHL after infection in T2 (person/Year) |
Default | CMV USA | DE,F | SNHL after seropositive transmission (person/Year) |
Default | CMV USA | C | switch 1 (contact/(person*Year)) |
Default | CMV USA | C | switch 2 (Dmnl) |
Default | CMV USA | C | switch 3 2 (Dmnl) |
Default | CMV USA | C | switch 3.1 (Dmnl) |
Default | CMV USA | C | switch 4 (contact/(person*Year)) |
Default | CMV USA | C | switch 5 (person/contact) |
Default | CMV USA | A | total population (person) |
Default | CMV USA | A | transmission rate after primary infection (Dmnl) |
Default | CMV USA | A | trimester (Year) |
Variable (43) | |||
Default | CMV USA | A | chance of transmission seropositive (Dmnl) |
Default | CMV USA | A | children contact rate (contact/(person*Year)) |
Default | CMV USA | A | contact rate among pregnant women (contact/(person*Year)) |
Default | CMV USA | A | fatality ratio of symptomatic infant (Dmnl) |
Default | CMV USA | DE,F | growth non infected between 2 and 3.5 (person/Year) |
Default | CMV USA | DE,F | healthy from seronegative deliveries (person/Year) |
Default | CMV USA | L | Infectious adults (person) |
Default | CMV USA | DE,F | infectious after seropositive transmission (person/Year) |
Default | CMV USA | DE,F | infectious after T1 (person/Year) |
Default | CMV USA | DE,F | infectious after T2 (person/Year) |
Default | CMV USA | L | Infectious children (person) |
Default | CMV USA | A | infectivity (person/contact) |
Default | CMV USA | A | inter adult contact rate (contact/(Year*person)) |
Default | CMV USA | DE,F | MR after primary infection in T1 (person/Year) |
Default | CMV USA | DE,F | MR after primary infection in T2 (person/Year) |
Default | CMV USA | DE,F | MR after seropositive transmission (person/Year) |
Default | CMV USA | F,A | non infected 2nd T (person/Year) |
Default | CMV USA | DE,F | non infected after T1 (person/Year) |
Default | CMV USA | DE,F | non infected after T2 (person/Year) |
Default | CMV USA | L | Non infected children (person) |
Default | CMV USA | DE,F | non infected from seropositive mothers (person/Year) |
Default | CMV USA | F,A | non infected T3 (person/Year) |
Default | CMV USA | L | Non infectious seropositive adults (person) |
Default | CMV USA | L | Non infectious seropositive children (person) |
Default | CMV USA | A | percentage of asymptomatic after T1 that shows signs of CNS (Dmnl) |
Default | CMV USA | A | percentage of infant T2 that shows CNS signs (Dmnl) |
Default | CMV USA | A | percentage of symptomatic after T1 that shows CNS signs (Dmnl) |
Default | CMV USA | A | Policy 1 (contact/(person*Year)) |
Default | CMV USA | A | Policy 2 (Dmnl) |
Default | CMV USA | A | Policy 3.1 (Dmnl) |
Default | CMV USA | A | Policy 3.2 (Dmnl) |
Default | CMV USA | A | Policy 4 (contact/(person*Year)) |
Default | CMV USA | A | Policy 5 (person/contact) |
Default | CMV USA | DE,F | seronegative adult death (person/Year) |
Default | CMV USA | L | Seronegative adults (person) |
Default | CMV USA | L | Seronegative pregnancies T2 (person) |
Default | CMV USA | L | Seronegative pregnancies T3 (person) |
Default | CMV USA | F,A | seropositive deliveries (person/Year) |
Default | CMV USA | DE,F | SNHL after infection in T1 (person/Year) |
Default | CMV USA | DE,F | SNHL after infection in T2 (person/Year) |
Default | CMV USA | DE,F | SNHL after seropositive transmission (person/Year) |
Default | CMV USA | A | transmission rate after primary infection (Dmnl) |
Default | CMV USA | A | trimester (Year) |
Variable | |||
Default | CMV USA | L | Children with CMV-induced Mental Retardation (person) |
Default | CMV USA | L | Children with CMV-induced SNHL aged 2 (person) |
Default | CMV USA | DE,F | growth non infected between 2 and 3.5 (person/Year) |
Default | CMV USA | DE,F | healthy from seronegative deliveries (person/Year) |
Default | CMV USA | L | Infectious adults (person) |
Default | CMV USA | DE,F | infectious after seropositive transmission (person/Year) |
Default | CMV USA | DE,F | infectious after T1 (person/Year) |
Default | CMV USA | DE,F | infectious after T2 (person/Year) |
Default | CMV USA | L | Infectious children (person) |
Default | CMV USA | L | Infectious healthy children aged 2 (person) |
Default | CMV USA | DE,F | MR after primary infection in T1 (person/Year) |
Default | CMV USA | DE,F | MR after primary infection in T2 (person/Year) |
Default | CMV USA | DE,F | MR after seropositive transmission (person/Year) |
Default | CMV USA | DE,F | non infected after T1 (person/Year) |
Default | CMV USA | DE,F | non infected after T2 (person/Year) |
Default | CMV USA | L | Non infected children (person) |
Default | CMV USA | L | Non infected children aged 2 (person) |
Default | CMV USA | DE,F | non infected from seropositive mothers (person/Year) |
Default | CMV USA | L | Non infectious seropositive adults (person) |
Default | CMV USA | L | Non infectious seropositive children (person) |
Default | CMV USA | L | Pregnancies of seropositive mothers (person) |
Default | CMV USA | DE,F | seronegative adult death (person/Year) |
Default | CMV USA | L | Seronegative adults (person) |
Default | CMV USA | L | Seronegative pregnancies T1 (person) |
Default | CMV USA | L | Seronegative pregnancies T2 (person) |
Default | CMV USA | L | Seronegative pregnancies T3 (person) |
Default | CMV USA | DE,F | SNHL after infection in T1 (person/Year) |
Default | CMV USA | DE,F | SNHL after infection in T2 (person/Year) |
Default | CMV USA | DE,F | SNHL after seropositive transmission (person/Year) |
Unused Variable (3) | |||
Default | CMV USA | A | Disabled children due to CMV (person) |
Default | CMV USA | A | fraction of CMV-induced disabled children (Dmnl) |
Default | CMV USA | A | Infected children (person) |